WeightWatchers going into prescription weight loss business with telehealth provider acquisition
CBC
WeightWatchers' stock soared on Tuesday after the company said it is getting into the prescription drug weight loss business with the acquisition of Sequence.
Sequence is a telehealth provider that offers users access to drugs used to treat diabetes and obesity under such brand names as Ozempic, Wegovy and Trulicity.
The drugs all work by the same mechanism: They trigger the release of insulin, block sugar production in the liver and suppress appetite.
WeightWatchers offers subscribers meal plans with the goal of losing excess weight. With the acquisition of Sequence, it is tapping into a red-hot market for prescription drugs that address obesity and broadening what it offers to customers.
"It is our responsibility, as the trusted leader in weight management, to support those interested in exploring if medications are right for them," CEO Sima Sistani said in a prepared statement late Monday.
Ozempic and Wegovy are different versions of the same drug, known as semaglutide.
They're both given as once-weekly injections. Ozempic is approved only to treat diabetes, although it has been increasingly prescribed for off-label use.
Wegovy was approved in 2021 to treat obesity in adults, and late last year to treat the condition in adolescents 12 and older. In a clinical trial, adults who used Wegovy lost about 15 per cent of their initial body weight, while teens lost slightly more.
For best results, the drugs should be combined with diet and exercise, experts say. Trulicity is a different drug, dulaglutide, used to treat diabetes in adults and children ages 10 and older. It's not approved to treat obesity.
The off-label use of semaglutide, spurred by social media posts, led to a shortage of the drug for most of last year. Novo Nordisk said supplies are being replenished, but many diabetes patients still report trouble accessing the drugs they need.
Both Ozempic and Wegovy can cause possible side-effects, the company reports. They include possible thyroid cancer, pancreatitis, and kidney and gallbladder problems.
The most common side-effects are nausea, vomiting, diarrhea, stomach pain and constipation. Obesity prevalence rose from 30.5 per cent from the 1999-2000 period to 41.9 per cent for 2017 through March 2020, according to the U.S. Centers for Disease Control and Prevention (CDC). The prevalence of severe obesity surged from 4.7 per cent to 9.2 per cent for the same periods.
Currently, Wegovy and Saxenda are approved drugs for obesity in the United States, with tirzepatide also widely expected to be approved for it later this year.
In December, Eli Lilly CEO David Ricks called the drug one of its "generational opportunities." The drug was last year approved for diabetes, for which it is sold under the brand Mounjaro.
A First Nations family recently appeared on a popular U.S. daytime talk show to showcase their own styles of powwow dance.
People in Canada have a new, less invasive way to test for HIV at home, following Health Canada's approval of an oral self-test.
Indiana University in Bloomington, Ind., is working with Nakota communities to return valuable cultural archives of recordings of their elders.
Children face five major risk factors early in life that can set them up to develop food allergies, says a Canadian-led team of researchers who sifted through studies on 2.8 million participants in 40 countries, one of the largest reviews of its kind.
Deep within a dark growing chamber in the bowels of a research lab at Acadia University, a lumpy white substance blooms up from an industrial tray.
Most of the world doesn’t require a prescription for birth control. Why do Canadians still need one?
Leah Morris has been on birth control since she was a teenager. She remembers that first appointment being deceptively simple.
Nearly $300M in federal contracts went to companies later removed from Indigenous Business Directory
Over $285 million in federal government contracts for Indigenous businesses were awarded over a five-year period to companies that have since been removed from its Indigenous Business Directory, according to a response to a written question in the House of Commons.
The Artemis II mission, which was initially supposed to launch on Feb. 8, has now been delayed by at least a month after NASA found a hydrogen leak while fuelling the tank.
Facing the reality that a majority of Canadian students are using generative AI for schoolwork, more educators are bringing artificial intelligence into their university classrooms, setting clear rules and encouraging students to use it responsibly — and with a critical eye.
Five more First Nations have joined a court challenge against new federal and provincial laws aimed at fast-tracking development, saying they threaten Indigenous rights.
Scientists who monitor Canada’s environmental health and protect Canadians from extreme weather events and industrial disasters could soon find themselves on the federal government’s chopping block.
The federal government is reviving proposed legislation that would allow digital health information to be shared safely across electronic systems, giving both patients and providers access to more comprehensive medical records.
Some First Nations in Saskatchewan will hold information sessions about making claims under the Federal Indian Hospitals Settlement. One lawyer from Keeseekoose First Nation says having to revisit the experience can be difficult and she wants to help.